Laxido Orange

Polyethylene glycol 3350, the active ingredient in Laxido Orange, is an osmotic laxative presented as a powder for oral solution for oral use. Combined with sodium hydrogen carbonate, potassium chloride and sodium chloride, the formulation draws water into the intestinal lumen, softening stool and facilitating bowel movements. It is indicated for the relief of occasional constipation in adults and children.

GNH USA supplies Laxido Orange as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company provides bulk quantities, adheres to EU quality standards, and supports global distribution through regulated channels, offering reliable logistics, product traceability, and compliance with international regulatory requirements.

Laxido Orange, an osmotic laxative, is used to manage conditions related to impaired bowel transit. - Constipation: softens stool and promotes regular bowel movements in individuals experiencing infrequent or difficult defecation. - Chronic constipation: provides ongoing relief by maintaining stool hydration for patients with long‑term constipation. - Functional constipation: improves bowel function in cases where constipation is not caused by structural abnormalities.

Laxido Orange may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Flatulence: increased intestinal gas. - Nausea: feeling of sickness or urge to vomit. - Diarrhea: loose, watery stools. - Stomach cramps: intermittent abdominal pain. - Increased stool frequency: more frequent bowel movements than usual.

Serious or Rare Side Effects: - Electrolyte imbalance: abnormal levels of sodium, potassium or chloride. - Severe dehydration: excessive loss of body fluids. - Allergic reaction: rash, itching, swelling or difficulty breathing. - Severe abdominal pain: intense, persistent pain in the abdomen. - Rectal bleeding: presence of blood in stool. - Persistent vomiting: ongoing vomiting that may lead to further fluid loss.

Before using Laxido Orange, consider the following precautions to ensure safe and effective use. - Assess renal function: evaluate kidney health, as impaired function may affect fluid balance. - Monitor electrolytes: check sodium and potassium levels during prolonged use. - Use with caution in dehydration: avoid if the patient is already dehydrated or has fluid loss. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Laxido Orange can interact with other medicines; awareness of these interactions helps prevent complications.

Major Interactions (Avoid): - Concurrent use with other osmotic laxatives: may cause severe electrolyte disturbances. - Combination with diuretics: can exacerbate fluid loss and dehydration. - Co‑administration with high‑dose potassium chloride supplements: may lead to potassium imbalance.

Moderate Interactions (Monitor Closely): - Oral medications requiring absorption: laxative may delay their uptake, reducing efficacy. - Antacids containing sodium bicarbonate: may alter the osmotic balance and affect stool consistency.